Page last updated: 2024-10-23

betaxolol and Obesity

betaxolol has been researched along with Obesity in 1 studies

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research Excerpts

ExcerptRelevanceReference
"The antihypertensive and metabolic effects of betaxolol (20 mg/day) were monitored in 40 patients (17 male), aged 54 +/- 2 yr (mean +/- SEM), with moderate essential hypertension."5.07Betaxolol in obese hypertensive patients. Long-term effects on blood pressure and serum lipids. ( van Brummelen, P; van Os, JS; Woittiez, AJ, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Os, JS1
van Brummelen, P1
Woittiez, AJ1

Trials

1 trial available for betaxolol and Obesity

ArticleYear
Betaxolol in obese hypertensive patients. Long-term effects on blood pressure and serum lipids.
    The Netherlands journal of medicine, 1992, Volume: 40, Issue:5-6

    Topics: Betaxolol; Blood Pressure; Cholesterol; Drug Evaluation; Female; Humans; Hypertension; Male; Middle

1992